Scholarlink

<p>Photoswitchable ligands enable reversible control of receptor signaling through light-induced <i>cis</i>–<i>trans</i> isomerization, yet predicting how subtle structural modifications affect efficacy remains challenging. Here, we use molecular dynamics simulations to investigate two azobenzene-based human 5–HT<sub>2A</sub> receptor ligands differing only by a methoxy substituent position (<i>para</i>– vs <i>meta</i>–methoxy). Compound <b>1</b> (<i>para</i>–methoxy) switches from acting as a weak antagonist (<i>trans</i>) to a moderate agonist (<i>cis</i>), whereas compound <b>2</b> (<i>meta</i>-methoxy) maintains agonist activity in both forms, with <i>cis</i>-<b>2</b> exhibiting the highest efficacy. Our simulations reveal&#xa0;that the key determinant of these efficacy differences lies in the vertical depth of ligand insertion into the orthosteric binding pocket. The <i>para</i>–methoxy moiety of <i>trans</i>–<b>1</b> forms hydrogen bonds with Asp231<sup>5.35</sup> and Thr160<sup>3.37</sup>, anchoring the ligand deeper than typical tryptamine agonists and preventing engagement with activation-critical residues, thereby stabilizing the inactive receptor. Conversely, <i>trans</i>–<b>2</b> lacks these anchoring interactions and adopts a shallower, agonist-compatible pose. In the active receptor, <i>cis</i>–<b>2</b> forms a persistent Thr160<sup>3.37</sup> hydrogen bond that allows deeper penetration between TM4 and TM5, whereas <i>cis</i>–<b>1</b>’s <i>para</i>–methoxy causes steric hindrances limiting this interaction. Based on these findings, we suggest that ligand insertion depth is a critical determinant of efficacy. This provides a framework for designing light-sensitive GPCR ligands with tunable signaling properties.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Binding pose depth modulates photoswitchable ligands’ efficacy at the 5-HT2A receptor

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月12日

查看全文
  • Verena Weber,
  • Giacomo Salvadori,
  • Federico Natale,
  • Hubert Gerwe,
  • Michael Decker,
  • Paolo Carloni,
  • Giulia Rossetti

摘要

Photoswitchable ligands enable reversible control of receptor signaling through light-induced cis–trans isomerization, yet predicting how subtle structural modifications affect efficacy remains challenging. Here, we use molecular dynamics simulations to investigate two azobenzene-based human 5–HT2A receptor ligands differing only by a methoxy substituent position (para– vs meta–methoxy). Compound 1 (para–methoxy) switches from acting as a weak antagonist (trans) to a moderate agonist (cis), whereas compound 2 (meta-methoxy) maintains agonist activity in both forms, with cis-2 exhibiting the highest efficacy. Our simulations reveal that the key determinant of these efficacy differences lies in the vertical depth of ligand insertion into the orthosteric binding pocket. The para–methoxy moiety of trans–1 forms hydrogen bonds with Asp2315.35 and Thr1603.37, anchoring the ligand deeper than typical tryptamine agonists and preventing engagement with activation-critical residues, thereby stabilizing the inactive receptor. Conversely, trans–2 lacks these anchoring interactions and adopts a shallower, agonist-compatible pose. In the active receptor, cis–2 forms a persistent Thr1603.37 hydrogen bond that allows deeper penetration between TM4 and TM5, whereas cis–1’s para–methoxy causes steric hindrances limiting this interaction. Based on these findings, we suggest that ligand insertion depth is a critical determinant of efficacy. This provides a framework for designing light-sensitive GPCR ligands with tunable signaling properties.